Intravesical injection of peripheral blood mononuclear cell for the treatment of interstitial cystitis: A preliminary report. [PDF]
Tsai CP +6 more
europepmc +1 more source
Impact of Chlorogenic Acid on Peripheral Blood Mononuclear Cell Proliferation, Oxidative Stress, and Inflammatory Responses in Racehorses during Exercise. [PDF]
Dąbrowska I +3 more
europepmc +1 more source
CXCL10, CXCL11, HLA-A and IL-1β are induced in peripheral blood mononuclear cells from women withChlamydia trachomatisrelated infertility [PDF]
Shruti Menon +4 more
openalex +1 more source
A matrix‐free human liver organoid–T cell co‐culture platform enables modeling of immune‐mediated drug‐induced liver injury (iDILI). Using flucloxacillin and patient‐matched cells, this system recapitulates HLA‐B*57:01–restricted CD8⁺ T cell activation and hepatocyte damage.
Fadoua El Abdellaoui Soussi +11 more
wiley +1 more source
Autologous peripheral blood mononuclear cell-loaded injectable cell scaffold (ICS-001) for revolutionising angiogenic therapy: a study protocol for an exploratory clinical trial. [PDF]
Yamahara K +15 more
europepmc +1 more source
In vitro generation of antigen-specific hemolytic plaque-forming cells from human peripheral blood mononuclear cells. [PDF]
J Misiti, T. A. Waldmann
openalex +1 more source
A novel therapy using engineered immune cells (NAC‐T cells) showed promise for refractory malignant mesothelioma. Based on the encouraging preclinical data, the first‐in‐human trial is initiated, demonstrating tolerable safety and promising anti‐tumor activity (ORR 63.6%, DCR 100%, including one CR).
Yan Sun +23 more
wiley +1 more source
Immunomodulatory Effects of High-Dose Irradiation Regimens in Renal Cell Carcinoma: Insights from an In Vitro Model with Human Peripheral Blood Mononuclear Cell. [PDF]
Meniai Merzouki F +6 more
europepmc +1 more source
Peripheral blood mononuclear cell hyperresponsiveness in patients with premature myocardial infarction without traditional risk factors. [PDF]
Mol JQ +14 more
europepmc +1 more source

